scholarly journals Myofibroblastic Differentiation

2020 ◽  
Author(s):  
Keyword(s):  
Myofibroblastic Differentiation

Gastric carcinosarcoma with neuroendocrine differentiation as the carcinoma component and leiomyosarcomatous and myofibroblastic differentiation as the sarcomatous component. Case report

Apmis ◽  
2006 ◽  
Vol 114 (3) ◽  
pp. 234-238 ◽  
Author(s):  
N. KURODA ◽  
K. OONISHI ◽  
S. IWAMURA ◽  
M. OHARA ◽  
T. HIROUCHI ◽  
...  
Keyword(s):  
Case Report ◽  
Neuroendocrine Differentiation ◽  
Sarcomatous Component ◽  
Component Case ◽  
Myofibroblastic Differentiation

Nasal Chondromesenchymal Hamartoma in Children

2001 ◽  
Vol 125 (3) ◽  
pp. 400-403 ◽  
Author(s):  
Chuen Hsueh ◽  
Swei Hsueh ◽  
Frank Gonzalez-Crussi ◽  
Ta-jen Lee ◽  
Jen-liang Su
Keyword(s):  
Immunohistochemical Study ◽  
Correct Diagnosis ◽  
S100 Protein ◽  
Soft Tissue Tumors ◽  
Biological Behavior ◽  
Ultrastructural Examination ◽  
Spindle Cells ◽  
Nasal Chondromesenchymal Hamartoma ◽  
Myofibroblastic Differentiation ◽  
Malignant Soft Tissue

Abstract Hamartoma in the nasal cavity of children is especially rare. Most documented cases occurred in infants, with characteristic histologic features of a mixture of various mesenchymal tissues. McDermott et al designated it nasal chondromesenchymal hamartoma in 1998, and it has since been considered a distinct clinicopathological entity. We report 2 such examples in a full-term male newborn and a 9-month-old boy, respectively. Histologically, both cases were characterized by a mixture of various mesenchymal elements, including spindle cells, collagen fibers, and irregular islands of osseous and chondroid tissue. Immunohistochemical study showed positivity to vimentin and S100 protein. Ultrastructural examination of case 1 demonstrated fibroblastic and myofibroblastic differentiation in tumor cells. There were 11 cases of nasal chondromesenchymal hamartoma in children published to date. The tumor has a benign biological behavior, and complete resection is the treatment of choice. It is apt to be misdiagnosed because of overlapping histologic features shared with a number of benign and malignant soft tissue tumors. Awareness of this entity is essential for correct diagnosis and adequate therapy.

scholarly journals Myofibroblastic Differentiation of Human Skeletal Muscle‐Derived Progenitors Is Inhibited by Pirfenidone

2015 ◽  
Vol 29 (S1) ◽  
Author(s):  
Yasaman Alinejad ◽  
Jennifer Downey ◽  
Genevieve Drouin ◽  
Meggie Morand ◽  
Alex Daviau ◽  
...  
Keyword(s):  
Skeletal Muscle ◽  
Human Skeletal Muscle ◽  
Myofibroblastic Differentiation

Breast sarcoma showing myofibroblastic differentiation

2003 ◽  
Vol 443 (2) ◽  
pp. 222-224 ◽  
Author(s):  
Ksenija Lucin ◽  
Elvira Mustac ◽  
Nives Jonjic
Keyword(s):  
Breast Sarcoma ◽  
Myofibroblastic Differentiation

scholarly journals Myofibroblastic Differentiation Leads to Hyaluronan Accumulation through Reduced Hyaluronan Turnover

2004 ◽  
Vol 279 (40) ◽  
pp. 41453-41460 ◽  
Author(s):  
Robert H. Jenkins ◽  
Gareth J. Thomas ◽  
John D. Williams ◽  
Robert Steadman
Keyword(s):  
Myofibroblastic Differentiation

scholarly journals Novel Anti-inflammatory Effects of the Inhaled Corticosteroid Fluticasone Propionate During Lung Myofibroblastic Differentiation

2001 ◽  
Vol 167 (9) ◽  
pp. 5329-5337 ◽  
Author(s):  
Eric Cazes ◽  
Julien Giron-Michel ◽  
Soria Baouz ◽  
Christelle Doucet ◽  
Francesca Cagnoni ◽  
...  
Keyword(s):  
Fluticasone Propionate ◽  
Inhaled Corticosteroid ◽  
Anti Inflammatory ◽  
Myofibroblastic Differentiation
Sign in / Sign up

Export Citation Format

Share Document